Treatment algorithms suggest weight loss is beneficial in the management of type 2 diabetes. Researchers sought to see whether phentermine-topiramate extended-release could potentially improve weight loss and improve glycemic control in overweight and obese patients with type 2 diabetes using double blind, randomized, placebo-controlled trials.

READ FULL ARTICLE Curated publisher From Diabetesjournals